SUSPENDED

Optoacoustic Detection of Inflammation Using MSOT Device

Talk to us

Conditions

Graft Vs Host DiseaseColitisCrohn DiseaseImaging deviceinflammatory diseases

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the safety and potential of a new experimental imaging instrument called multispectral optoacoustic tomography (MSOT) to detect inflammation in patients with chronic graft versus host disease of the skin or GI tract, Crohn's disease, or Colitis disease.

Official Title

Optoacoustic Detection of Inflammation Using Multispectral Optoacoustic Tomography

Quick Facts

Study Start:2022-05-31
Study Completion:2028-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT05333978

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients documented clinical/pathologic 1) acute or chronic colon or skin GVHD, 2) Crohn's disease, or 3) colitis
  2. * Have acceptable hematologic status \[total hemoglobin (tHb) ≥ 7.0 mg/dL\]
  3. * Patients ≥ 18 yrs of age
  4. * Willing to comply with study procedures and be available for the duration of the study
  5. * Patient has ability to understand and the willingness to provide a signed and dated IRB-approved informed consent document.
  1. * Patients with a tattoo over the area of inflammation
  2. * Pregnant patients are not eligible for this trial. Eligible patients (if applicable) will be required to document the date of the first day of their last menstrual cycle, and provide a negative pregnancy test if sexually active and of childbearing potential
  3. * Patients who are breastfeeding
  4. * Any open wound (skin ulcerations or infections) at or near the site of imaging that would preclude MSOT imaging.
  5. * Any febrile illness that precludes or delays participation preoperatively

Contacts and Locations

Principal Investigator

Lacey McNally, PhD
PRINCIPAL_INVESTIGATOR
University of Oklahoma

Study Locations (Sites)

University of Oklahoma Health Sciences Center, Stephenson Cancer Center
Oklahoma City, Oklahoma, 73014
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Lacey McNally, PhD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-31
Study Completion Date2028-05-01

Study Record Updates

Study Start Date2022-05-31
Study Completion Date2028-05-01

Terms related to this study

Keywords Provided by Researchers

  • Imaging device
  • inflammatory diseases

Additional Relevant MeSH Terms

  • Graft Vs Host Disease
  • Colitis
  • Crohn Disease